Graduate School of Health Sciences, Sapporo Medical University, Sapporo, Japan.
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
EBioMedicine. 2017 Sep;23:12-19. doi: 10.1016/j.ebiom.2017.07.023. Epub 2017 Jul 26.
In addition to the primary symptoms arising from inflammatory processes in the joints, muscle weakness is commonly reported by patients with rheumatoid arthritis (RA). Muscle weakness not only reduces the quality of life for the affected patients, but also dramatically increases the burden on society since patients' work ability decreases. A 25-70% reduction in muscular strength has been observed in pateints with RA when compared with age-matched healthy controls. The reduction in muscle strength is often larger than what could be explained by the reduction in muscle size in patients with RA, which indicates that intracellular (intrinsic) muscle dysfunction plays an important role in the underlying mechanism of muscle weakness associated with RA. In this review, we highlight the present understanding of RA-associated muscle weakness with special focus on how enhanced Ca release from the ryanodine receptor and free radicals (reactive oxygen/nitrogen species) contributes to muscle weakness, and recent developments of novel therapeutic interventions.
除了关节炎症引起的主要症状外,类风湿关节炎(RA)患者通常还会报告肌肉无力。肌肉无力不仅降低了受影响患者的生活质量,而且由于患者的工作能力下降,对社会造成了巨大的负担。与年龄匹配的健康对照组相比,RA 患者的肌肉力量下降了 25-70%。肌肉力量的下降通常比 RA 患者肌肉大小减少所解释的要大,这表明细胞内(内在)肌肉功能障碍在 RA 相关肌肉无力的潜在机制中发挥重要作用。在这篇综述中,我们重点介绍了目前对 RA 相关肌肉无力的理解,特别关注肌浆网钙释放增强和自由基(活性氧/氮物种)如何导致肌肉无力,以及新的治疗干预措施的最新进展。